Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: A double-blind randomized, placebo-controlled multicenter trial - 18/08/11
Reprint requests: Walter Tschugguel, MD, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.Abstract |
Objective |
We aimed to determine whether second-trimester abortion using isosorbide mononitrate (IMN) in addition to gemeprost is more effective and reduces side effects compared with gemeprost alone.
Study design |
Eighty women who were age 13 to 23 weeks' gestation were randomly assigned to receive per vaginam either IMN 40 mg (group 1, 40 women) or placebo (group 2, 40 women) in addition to gemeprost 1 mg up to 3 times daily 3 hours apart for 2 days. Analysis of variance, a χ2 test, and a multivariate analysis were performed.
Results |
Of the 72 women analyzed, 68% (group 1) and 38% (group 2) underwent abortion within day 1 (P < .05). However, group 1 was associated with more headache (18% of women) 3 hours after induction compared to group 2 (0% of women, P=.038).
Conclusion |
IMN in addition to gemeprost is effective for second-trimester abortion, but is associated with more headache compared with gemeprost alone.
Le texte complet de cet article est disponible en PDF.Key words : Gemeprost, Isosorbide mononitrate, Second trimester, Abortion
Plan
Vol 192 - N° 3
P. 856-861 - mars 2005 Retour au numéro
Article précédent
- Maternal age and the likelihood of a maternal request for cesarean delivery: A 5-year population-based study
- Herng-Ching Lin, Sudha Xirasagar
- Risk factors for neonatal mortality among extremely-low-birth-weight infants
- Stephen J. Bacak, Kesha Baptiste-Roberts, Erol Amon, Belinda Ireland, Terry Leet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?